RenovoRx, Inc.
RNXT
$0.86
-$0.03-2.89%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -19.72% | -1.00% | -0.59% | -19.63% | 15.91% |
| Total Depreciation and Amortization | 0.00% | 200.00% | -200.00% | 0.00% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 320.71% | -200.51% | -72.45% | 360.95% | -146.44% |
| Change in Net Operating Assets | -630.51% | -73.54% | 462.60% | 82.12% | -384.51% |
| Cash from Operations | -22.81% | -33.04% | 1.39% | 31.91% | -39.14% |
| Capital Expenditure | -- | -- | -- | 100.00% | 83.33% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | 100.00% | 83.33% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 3,720.59% | -99.72% | 434.66% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 100.00% | -- | -- | 41.80% |
| Cash from Financing | -- | -- | -100.00% | -99.69% | 32,660.61% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 276.75% | -33.04% | -0.09% | -130.53% | 408.34% |